Uppsala

Sweden

349 total trials 141 recruiting

Filter these 349 trials by phase, condition, sponsor and more.

Open in Search →

A Study Evaluating the Efficacy and Safety of Neoadjuvant Treatment with Atezolizumab or Placebo in Combination with Platinum-Based Chemothe … Ended

2023-504209-35-00 5 2018-04-04 Early-Stage Resectable Non-small cell lung cancer (NSCLC)
A prospective, multicenter, phase-II trial of ibrutinib plus venetoclax in physically fit patients with creatinine clearance ≥ 30 ml/min who … Ended

2023-510557-42-00 4 2017-07-10 chronic lymphocytic leukemia
A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy … Ended

2022-501382-49-00 5 2017-03-07 Triple Negative Breast Cancer (TNBC)
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea … Ended

2024-511235-10-00 5 2016-07-25 Generalized mantle cell Lymphoma
HD21 Ended

2024-518022-33-00 5 2016-07-15 Advanced Stage of Hodgkin Lymphoma
A Phase III, Randomized, Open-label, Clinical Trial to Compare Pembrolizumab with Brentuximab Vedotin in Subjects with Relapsed or Refractor … Ended

2022-500400-22-00 5 2016-06-23 Hodgkin lymphoma
Pembrolizumab (MK-3475) and pembrolizumab in combination with other investigational agents in high risk NMIBC patients unresponsive to BCG Ended

2022-502526-41-00 4 2016-03-15 Non-Muscle Invasive Bladder Cancer (NMIBC)
Treatment of neuroendocrine neoplasms with genetically modified adenovirus Ended

2024-517654-10-00 1 2016-03-15 Neuroendocrine neoplasms (NENs) is a heterogeneous group with varying
ME-401 combined with rituximab-bendamustine for high-risk and rituximab with a 1:1 randomization to ME-401 for low-risk follicular lymphoma … Ended

2022-501138-49-00 4 Follicular Lymphoma
Phase 1/2 Study of Belzutifan Plus Palbociclib Versus Belzutifan in Advanced Renal Cell Carcinoma (RCC) Ended

2023-504963-17-00 9 Advanced ccRCC
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan … Ended

2023-506487-13-00 5 Hormone receptor-positive, her2-negative advanced/metastatic breast ca
Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) Ended

2024-512407-39-00 6 Chronic obstructive pulmonary disease
MESENCHYMAL STROMAL CELL THERAPY FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME - Validation of Mechanistic Pathways and Clinical … Ended

2024-518160-13-00 1 Acute Respiratory Distress Syndrome - ARDS

Showing 337–349 of 349 trials